Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion

Abstract A major obstacle in knocking down oncogenes for tumor therapy is the efficient delivery of siRNA into the cytosolic spaces of cancer cells. Here, we genetically bioengineer biomimetic nanovesicles with tumor-recognition and enzyme-controlled membrane fusion functions for efficiently deliver...

Full description

Saved in:
Bibliographic Details
Main Authors: Lele Cui, Yongsheng Cui, Jing Liu, Wei Li, Mengdan Wu, Xiawei Wei, Ying Lai, Peng Mi
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-61230-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238262379446272
author Lele Cui
Yongsheng Cui
Jing Liu
Wei Li
Mengdan Wu
Xiawei Wei
Ying Lai
Peng Mi
author_facet Lele Cui
Yongsheng Cui
Jing Liu
Wei Li
Mengdan Wu
Xiawei Wei
Ying Lai
Peng Mi
author_sort Lele Cui
collection DOAJ
description Abstract A major obstacle in knocking down oncogenes for tumor therapy is the efficient delivery of siRNA into the cytosolic spaces of cancer cells. Here, we genetically bioengineer biomimetic nanovesicles with tumor-recognition and enzyme-controlled membrane fusion functions for efficiently delivering small interfering RNA into cancer cells towards gene silencing tumor therapy. The siRNA@eS-BNVs are formulated by encapsulating siRNA inside the core and coating with genetically engineered HEK293TACE2- cell membranes encoded with functional S protein, which can recognize cancer cells and initiate membrane fusion when triggered by the enzyme. The siRNA@eS-BNVs demonstrate better efficacy for cytosolic siRNA delivery and RNA interference than conventional formulations. By intravenous injection, siRNA@eS-BNVs are highly accumulated in tumors and potently inhibited tumor and lung metastasis by simultaneously silencing the epidermal growth factor receptor gene in vivo. The cancer cell-targeting and enzyme-activatable nanovesicles provide a valuable strategy for effective and precise drug delivery.
format Article
id doaj-art-e9229b6cc3cd4258aa430bec4763bfd6
institution Kabale University
issn 2041-1723
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-e9229b6cc3cd4258aa430bec4763bfd62025-08-20T04:01:41ZengNature PortfolioNature Communications2041-17232025-07-0116112010.1038/s41467-025-61230-1Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusionLele Cui0Yongsheng Cui1Jing Liu2Wei Li3Mengdan Wu4Xiawei Wei5Ying Lai6Peng Mi7Department of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityDepartment of Radiology, Huaxi MR Research Center (HMRRC), National Clinical Research Center for Geriatrics, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan UniversityAbstract A major obstacle in knocking down oncogenes for tumor therapy is the efficient delivery of siRNA into the cytosolic spaces of cancer cells. Here, we genetically bioengineer biomimetic nanovesicles with tumor-recognition and enzyme-controlled membrane fusion functions for efficiently delivering small interfering RNA into cancer cells towards gene silencing tumor therapy. The siRNA@eS-BNVs are formulated by encapsulating siRNA inside the core and coating with genetically engineered HEK293TACE2- cell membranes encoded with functional S protein, which can recognize cancer cells and initiate membrane fusion when triggered by the enzyme. The siRNA@eS-BNVs demonstrate better efficacy for cytosolic siRNA delivery and RNA interference than conventional formulations. By intravenous injection, siRNA@eS-BNVs are highly accumulated in tumors and potently inhibited tumor and lung metastasis by simultaneously silencing the epidermal growth factor receptor gene in vivo. The cancer cell-targeting and enzyme-activatable nanovesicles provide a valuable strategy for effective and precise drug delivery.https://doi.org/10.1038/s41467-025-61230-1
spellingShingle Lele Cui
Yongsheng Cui
Jing Liu
Wei Li
Mengdan Wu
Xiawei Wei
Ying Lai
Peng Mi
Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
Nature Communications
title Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
title_full Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
title_fullStr Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
title_full_unstemmed Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
title_short Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion
title_sort bioengineered nanovesicles for efficient sirna delivery through ligand receptor mediated and enzyme controlled membrane fusion
url https://doi.org/10.1038/s41467-025-61230-1
work_keys_str_mv AT lelecui bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT yongshengcui bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT jingliu bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT weili bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT mengdanwu bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT xiaweiwei bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT yinglai bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion
AT pengmi bioengineerednanovesiclesforefficientsirnadeliverythroughligandreceptormediatedandenzymecontrolledmembranefusion